イチキ ヨシノブ
ICHIKI Yoshinobu
市来 嘉伸 所属 埼玉医科大学 医学部 国際医療センター 呼吸器外科 職種 専任講師 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | Sleeve lobectomy for patients with non-small cell lung cancer. |
掲載誌名 | 正式名:International journal of surgery (London, England) |
巻・号・頁 | 8(1),39-43頁 |
著者・共著者 | Takeshi Hanagiri,Tetsuro Baba,Yoshinobu Ichiki,Manabu Yasuda,Masakazu Sugaya,Kenji Ono,Hidetaka Uramoto,Mitsuhiro Takenoyama,Kosei Yasumoto |
発行年月 | 2010 |
概要 | PURPOSE: A sleeve lobectomy for lung cancer is a procedure intended both for the maintenance of lung function and for radical treatment. We investigated the clinico-pathological features and treatment responses of lung cancer patients who underwent sleeve lobectomy in our department. SUBJECTS: Among the 984 patients with non-small cell lung cancer who underwent resection in our department between 1994 and 2007, the subjects were 24 patients in whom a sleeve lobectomy was performed. RESULTS: There were 18 male and 6 female patients, with a mean age of 65 years. The histological type was diagnosed as squamous cell carcinoma in 14 patients, and adenocarcinoma in 10. Patients with either mucoepidermoid carcinoma (n=1) or carcinoid tumor (n=1) were excluded. The pathological stage was evaluated as IA, IB, II, IIIA, IIIB, and IV in 4, 1, 8, 8, 2, and 1 patient, respectively. Regarding post-operative complications, 4 patients required sputum aspiration with a bronchoscope from the 2nd to 7th post-operative day due to sputum retention. The 5-year survival rate in patients who underwent sleeve lobectomy was 70.0%. According to the pathological nodal status, the 5-year survival rates of N0, |
DOI | 10.1016/j.ijsu.2009.10.004 |
PMID | 19850158 |